IRB, FDA, NIH, CRC, ACTG. The clinical research acronym salad has no croutons, but it does shape the future of medicine.

Susan Moist, director of clinical trial operations at the UNC Center for Gastrointestinal Biology and Disease, joins hosts Michael Sledge, vice president and chief business officer of the UNC School of Medicine’s Clinical Research Alliance (CRA), and Dr. John Buse to decode the acronyms that run clinical research.

They cover who does what at UNC, the approvals a study needs before it opens, where the funding comes from and the people who run a trial day to day. Plus, what GLP-1, the one acronym on the list most listeners already know, has to do with all the others.

Connect with the CRA on LinkedIn: https://www.linkedin.com/company/unc-clinical-research-alliance/

Learn more about working with the CRA: https://www.med.unc.edu/unccra

GLP-1, CRA, IRB, FDA… Decoding the Acronym Salad

Dr. Nick Shaheen returns to look at the system behind individual studies.

Shaheen, senior associate dean for clinical research at the UNC School of Medicine and director of the North Carolina Translational and Clinical Sciences Institute (NC TraCS), joins Michael Sledge, vice president and chief business officer of the UNC School of Medicine’s Clinical Research Alliance (CRA), and Dr. John Buse.

They talk through the role NC TraCS and the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) program play in research at UNC, and why the “science of science” matters for making trials better, cheaper and faster.

Connect with the CRA on LinkedIn: https://www.linkedin.com/company/unc-clinical-research-alliance/

Learn more about working with the CRA: https://www.med.unc.edu/unccra

The Multi-Million Dollar Team Sport

How do raw steaks in a hotel room tie into research on Barrett's Esophagus? Dr. Nick Shaheen has the answer.

Michael Sledge, vice president and chief business officer of the UNC School of Medicine's Clinical Research Alliance (CRA), and Dr. John Buse start with why clinical trials are so underappreciated. Then Dr. Shaheen, senior associate dean for clinical research at the UNC School of Medicine and Director of the North Carolina Translational and Clinical Sciences Institute (NC TraCS), reflects on his Barrett's esophagus trials.

Connect with the CRA on LinkedIn: https://www.linkedin.com/company/unc-clinical-research-alliance/

Learn more about working with the CRA: https://www.med.unc.edu/unccra

The Sausage, the Science and the Impact 

Clinical trials don't run on science alone. They run on people, systems and decisions that almost nobody outside of the work ever sees.

Michael Sledge, vice president and chief business officer of the UNC Clinical Research Alliance (CRA), and Dr. John Buse talk with investigators, coordinators and staff who build, fund and run them, and dig into why good studies stall for reasons that have nothing to do with the science.

Connect with the CRA on LinkedIn: https://www.linkedin.com/company/unc-clinical-research-alliance/

Learn more about working with the CRA: https://www.med.unc.edu/unccra

The Trials & Tribulations Podcast

Clinical trials don't run on science alone. They run on people, systems and decisions that almost nobody outside the work ever sees. Michael Sledge, president and chief business officer of the UNC Cli

Trials & Tribulations · Zencastr

Trials & Tribulations

Clinical trials don't run on science alone. They run on people, systems and decisions that almost nobody outside the work ever sees. Michael Sledge, president and chief business officer of the UNC Clinical Research Alliance (CRA) and Dr. John Buse, therapeutic area director at the CRA, talk with investigators, coordinators and staff who build, fund and run trials, and dig into why good studies stall for reasons that have nothing to do with the science.